{
    "2019-11-28": [
        [
            {
                "time": "",
                "orginal_text": "重磅！医保谈判爆出大利好，救命药最高降60%！",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "救命药",
                        "降价",
                        "60%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医保谈判结果公布，利好国产创新企业",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "国产创新",
                        "企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "创新企业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医保药品谈判结果出炉 这些医药上市公司最受益",
                "features": {
                    "keywords": [
                        "医保药品",
                        "谈判结果",
                        "上市公司",
                        "受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "上市公司"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "第二批药品集采落地，处方药厮杀正酣，OTC药企机会来了",
                "features": {
                    "keywords": [
                        "药品集采",
                        "处方药",
                        "OTC药企",
                        "机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "OTC药企"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}